Business Standard

Torrent Pharma posts Rs 118 cr Q4 loss vs Rs 324 cr profit a year ago

The red line comes amid headwinds in EU operatopns and discontinuation of liquids business in the US; revenue, however, grows by 10%

pharmacy, drugs, medicine, pharma companies, pharmaceuticals, vaccine, coronavirus, covid, testing
Premium

Vinay Umarji Ahmedabad
On the back of headwinds in its EU business and discontinuation of liquids business in the US, Torrent Pharmaceuticals Ltd. (TPL) posted a net loss of Rs 118 crore for the fourth quarter ended March 31, 2022. On a year-on-year (YoY) basis, the company had registered a profit after tax (PAT) of Rs 324 crore in the corresponding quarter of last year.

The company's revenue, however, grew by 10 per cent to Rs 2,131 crore in Q4 of FY22 aided by strong growth momentum in branded generic markets. Torrent Pharma's revenue for Q4 FY21 was Rs 1937 crore. On an

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in